TriMas (TRS) 2026 年第三季法說會：重申 EPS 財測指引

重點摘要

• 第三季淨銷售額年增 7.7% 至 1.787 億美元，其中包括包裝與特種產品末端市場 7.2% 的有機成長。
• 調整後營業利益增長 47.9% 至 1,360 萬美元，營業利益率則擴展 200 個基點至 7.6%。
• 在獲利能力提升、投資收益增加及流通在外股數減少的支撐下，調整後每股盈餘從 0.17 美元增至 0.50 美元。
• 包裝業務銷售額成長 8.8% 至 1.48 億美元，營業利益率上升 40 個基點至 13.8%。特種產品銷售額增長 2.7%，但受 Norris Cylinder 製造效率低下影響，營業利益降至 10 萬美元。
• 管理層重申全年調整後每股盈餘財測為 1.60 美元至 1.70 美元，並將包裝與特種產品的合計銷售成長展望上調至 4%–6%。
• TriMas 在本季結束時擁有超過 11 億美元的現金及約 7.61 億美元的淨現金，為併購、有機投資及股東回報提供了資金空間。

核心財務數據

2026 年前九個月，淨銷售額增長 6.4% 至 5.216 億美元。營業利益成長 35.8% 至 4,120 萬美元，調整後每股盈餘則倍增以上達到 1.25 美元。

業務與營運表現

包裝業務

包裝業務第三季銷售額為 1.48 億美元，成長 8.8%，其中包含約 8.2% 的有機成長。此增長主要由銷量推動，美容與個人護理、食品與飲料、生命科學及工業應用領域的需求均有所成長。

營業利益成長 11.9% 至 2,040 萬美元，營業利益率提升至 13.8%。銷量提升、生產力改善及成本削減支撐了獲利能力。然而，高於預期的樹脂成本和不利的產品組合限制了利潤率的提升。

TriMas 同意將其袋裝盒軟包裝業務 Rapak 出售給 Ringmetall。該交易預期於 11 月初完成。Rapak 的年銷售額約為 2,000 萬美元，且利潤率低於平均水準，因此管理層預計本次處分將改善包裝業務的產品組合。

特種產品

特種產品銷售額成長 2.7% 至約 3,100 萬美元。Norris Cylinder 市佔率的提升與健全的客戶需求，被生產吞吐量限制部分抵銷。

營業利益從 240 萬美元降至 10 萬美元。機器停機、勞力生產力低落、生產瓶頸以及高昂的鋼材成本，抵銷了銷售增長帶來的效益。

管理層加強了 Norris Cylinder 的營運領導團隊，並表示在法說會進行時，受到停機影響的兩台關鍵機器已接近預期的運作水準。公司預計改善趨勢將持續，但要全面恢復至可持續的目標利潤率仍需時間。

資本配置

從宣布處分航太業務到第三季末，TriMas 投入了近 1.84 億美元進行股票回購。共回購了超過 540 萬股，今年以來已使流通在外股數減少超過 5%。在現有的授權額度下，仍剩餘約 6,700 萬美元。

該公司大部分現金存放於計息帳戶中，在本季獲得約 3.9% 的平均殖利率。管理層表示將持續評估併購機會，特別是在特定的生命科學與高階包裝市場，但在戰略契合度與回報率方面仍維持嚴謹紀律。

管理層財測展望

• 調整後每股盈餘：重申 2026 全年為 1.60 美元至 1.70 美元。
• 合計銷售成長：包裝與特種產品預計將增長 4%–6%，其中包含處分 Rapak 帶來的預期影響。
• 營業利益率：儘管 Norris Cylinder 的產能吞吐問題延續，管理層仍預期全年將擴展約 250 個基點。
• 包裝業務：預計全年銷售成長為 4%–5%，營業利益率接近 14%。
• 特種產品：預計全年銷售成長為 7%–10%，而營業利益率財測下修至 4%–6%。
• 第四季：管理層預期銷售額、獲利和每股盈餘將實現年增。同時預計第四季將是 2026 年自由現金流最強勁的季度。

該展望假設今年剩餘時間內，不會對處分航太業務的剩餘收益進行重大重新部署。

風險與關注焦點

• Norris Cylinder 持續面臨設備可靠性、勞力生產力及吞吐量挑戰。管理層認為這些問題屬於內部暫時性問題，但預期復甦時間將延伸至第四季之後。
• 包裝業務的價格與成本復甦速度低於預期，主因樹脂價格降幅不如預期迅速。管理層預期合約定價機制將隨時間抵銷成本波動。
• 由於假期安排與出貨量減少，第四季營收通常呈現季節性偏低。
• 由於管理層仍在根據其戰略與財務標準評估機會，未來併購的時間點與條款仍具不確定性。

分析師問答重點

• 併購優先事項：管理層仍專注於特定的生命科學機會及有助於打造更高階產品組合的包裝資產。本次未宣佈任何交易。
• 處分 Rapak：出售主要是一項精簡產品組合的舉措，而非擴充產能的計畫。大部分 Rapak 生產設施將隨同業務一併轉移。
• Norris Cylinder 復甦：隨著關鍵機器恢復運作，管理層預計第四季利潤率將實現季增，但也表示全面的營運復甦仍需額外時間。
• 現金流季節性：營運資金投資通常在年初最高。預計第四季活動減少將釋放庫存與應收帳款，支援更強勁的現金產生能力。
• 2027 年狀況：管理層未提供 2027 年財測，但表示營運舉措正在發揮成效，且在法說會進行時需求保持穩定。

完整財報電話會議記錄

完整財報電話會議逐字稿

管理層陳述

Operator

Greetings. Welcome to the TriMas Third Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to Sherry Lauderback, Vice President, Investor Relations. Thank you, Sherry. You may begin.

Sherry Lauderback

Thank you, and welcome to TriMas Corporation's Third Quarter 2026 Earnings Call. Joining me today are Thomas Snyder, President and CEO; and Paul Swart, our Chief Financial Officer. We'll begin with prepared remarks discussing our third quarter results, followed by our outlook for the remainder of 2026, after which we will open the call for questions from our analysts.

To help you follow along with today's discussion, both the press release and our presentation are available on our website at trimas.com under the Investors section. A replay of this call will also be available later today by dialing (877) 660-6853 and using meeting ID number 1376-3096. Before we begin, I'd like to remind everyone that today's comments may include forward-looking statements, which are inherently subject to various risks and uncertainties.

Please refer to our most recent Forms 10-K and 10-Q for a discussion of the factors that could cause our results to differ from those anticipated in any forward-looking statements. We undertake no obligation to publicly update or revise such statements, except as required by law. We also encourage you to visit our website for more information. In addition, please refer to the appendix of our press release or presentation for reconciliations of GAAP to non-GAAP financial measures. Throughout today's call, our discussion of financial results will be on an adjusted basis, excluding the impact of special items. And unless otherwise noted, the financial results discussed will reflect continuing operations. At this point, I'll turn the call over to Tom. Tom?

Thomas Snyder

Thank you, Sherry, and good morning, everyone. We appreciate you joining us today. Before we review our third quarter results, I'd like to take a few moments to update you on the steps we are taking to strengthen TriMas and the progress we are making against our 2026 priorities. As we approach the end of the year, we remain focused on advancing our key initiatives and positioning TriMas for sustainable growth and long-term value creation. While our third quarter results do not yet fully reflect the benefits of all the actions underway, we are encouraged by the progress we have made and the foundation we continue to build for the future. As a reminder, our strategy continues to be centered around 3 core pillars: customer success, our people and operational excellence. These priorities guide our decisions across the organization and continue to shape how we deliver products and services that empower customer success and drive long-term value for our stakeholders. A significant focus throughout 2026 has been driving improved execution and organizational effectiveness across the company.

The cost reduction and organizational realignment actions announced earlier this year remain on track and are contributing to year-over-year profit improvement. Our previously announced cost reduction actions totaling $10.5 million in expected 2026 savings and $16 million on an annualized basis continue to proceed as planned. From an operational perspective, our focus remains on driving continuous improvement in safety, quality, cost and on-time delivery through operational excellence initiatives across the portfolio. Performance across TriMas Packaging is generally progressing as planned. As we continue to advance operational excellence initiatives, we are beginning to see improvements in our key KPIs as those efforts gain traction.

Within our Specialty Products segment, we continue to address the operational and equipment throughput challenges that began impacting performance in the second quarter. While improvement has taken longer than anticipated, we have implemented targeted actions to increase equipment reliability and reduce operational costs.

We remain focused on restoring performance quickly and are encouraged by the recent progress we are beginning to see. Paul will provide additional details on the performance of our businesses and the trends we are seeing across the portfolio later in the call.

We also remain closely engaged with our customers and suppliers to support execution of our plan while strengthening relationships and responding effectively to evolving market conditions. These collaborations remain critical as we navigate changing demand patterns, manage supply chain dynamics and strengthen our ability to capitalize on future growth opportunities. A key component of all these improvement efforts is ensuring we have the right talent and leadership in place across the organization.

In packaging, our previously discussed leadership changes are already making significant contributions to our commercial and operational initiatives, helping to strengthen customer execution and overall operating performance. More recently, we made changes to strengthen operational leadership at Norris Cylinder to accelerate execution and advance performance improvement efforts.

Together, these leadership changes strengthen our bench, improve operational effectiveness and position TriMas to achieve its next phase of growth and performance improvement. Turning to our portfolio initiatives. We recently signed an agreement to divest Rapak, our flexible bag-in-box business to Ringmetall, a global packaging solutions company. Expected to close in early November, the transaction represents another important step in streamlining our portfolio and increasing our focus on businesses and end markets where we believe we have the greatest opportunity to drive profitable growth and attractive returns. We are also pleased to have found a strong strategic owner for Rapak and one that is well positioned to support the business' continued growth and success going forward. Beyond optimizing our portfolio, we continue to focus on disciplined capital allocation to ensure we are deploying resources in a manner that supports our strategic objectives and maximizes returns.

We remain focused on deploying capital in a balanced and smart manner, supporting investments in the business, pursuing strategic growth opportunities and returning capital to shareholders. We continue to prioritize investments that support organic growth, productivity improvements and innovation while evaluating targeted acquisition opportunities that will strengthen our platforms. We also remain committed to returning capital to shareholders. During the third quarter, we continued to repurchase shares, bringing total repurchases since the announcing the Aerospace divestiture to more than 5.4 million shares.

Year-to-date, our repurchase activity has contributed to a reduction in shares outstanding of more than 5%, demonstrating our confidence in the long-term value of the business. As of the quarter end, we still had approximately $67 million remaining under our existing share repurchase authorization.

Our balance sheet remains a significant competitive advantage and provides us with substantial strategic flexibility. While we do not have an acquisition announcement to share today, our strategic investment committee and management team remain actively engaged in evaluating the pipeline of opportunities. We continue to assess these opportunities through a rigorous strategic and financial lens, focusing on opportunities that strengthen our portfolio, support our growth objectives and meet our return expectations.

We recognize investors are eager to see the deployment of remaining aerospace proceeds. However, we remain convinced that patience and discipline will ultimately deliver the greatest opportunity to create sustainable shareholder value. In the meantime, the proceeds continue to generate attractive investment income while preserving the flexibility to act decisively when the right opportunities emerge.

Looking ahead, we remain patient and disciplined in our approach and believe the acquisition environment will continue to evolve, creating opportunities to deploy the capital at attractive returns over time.

Overall, we are encouraged by the progress we have made throughout 2026. While there's more work ahead, we believe we have built the right team and have the right strategy in place to drive stronger performance and create long-term shareholder value.

Let's now turn to our third quarter and year-to-date results on Slide 4. Our third quarter performance included strong year-over-year growth in sales, profitability and earnings, reflecting continued demand across our major end markets and the benefits of our cost reduction initiatives. Third quarter net sales increased 7.7% to $178.7 million, including organic growth of 7.2%, supported by growth across all major end markets served by our Packaging and Specialty Products businesses. Operating profit increased 47.9% to $13.6 million, while operating profit margin expanded 200 basis points to 7.6%. These results reflect the benefit of our cost reduction actions and organizational realignment initiatives, along with continued focus on operational execution across the platform.

Adjusted earnings per share increased to $0.50 compared with $0.17 in the prior year period. The increase was driven by stronger profitability, higher interest income on invested proceeds and the benefit of a lower share count resulting from our ongoing share repurchase activity. While performance in Specialty Products continue to be impacted by the throughput challenges at Norris Cylinder, the broader portfolio delivered solid results, demonstrating the benefits of the actions we have taken throughout the year.

The year-to-date results tell a similar story. Through the first 9 months of 2026, net sales increased 6.4% to $521.6 million. Operating profit increased 35.8% to $41.2 million and earnings per share more than doubled to $1.25. These results reflect a combination of organic growth and disciplined execution of our cost actions and the benefit of higher interest income on the aerospace proceeds. As we look at our performance throughout the first 9 months of the year, we are pleased with the progress we have made. While work remains, particularly with specialty products, the actions we have taken through 2026 are improving our business and positioning TriMas for continued progress moving forward. With that, I'll now turn the call over to Paul to review the financial results and business performance in more detail. Paul?

Paul Swart

Thank you, Tom, and good morning, everyone. I'll begin my comments on Slide 5 with an overview of our balance sheet and capitalization. We continue to maintain a strong financial position following the Aerospace divestiture, ending the third quarter with more than $1.1 billion in cash and a net cash position of approximately $761 million. Our strong balance sheet provides substantial flexibility as we continue to evaluate opportunities to support organic growth, execute disciplined M&A and return additional capital to shareholders. Since announcing the Aerospace transaction, we have remained disciplined in executing our balanced capital allocation strategy.

Through the end of the third quarter, we spent nearly $184 million to repurchase our shares, reflecting our confidence in the business and our commitment to creating shareholder value while preserving substantial liquidity. We also continue to fund the income tax obligation associated with the Aerospace transaction, now having paid approximately 2/3 of the obligation through the end of the third quarter. We purchased tax credits on a discounted basis, helping lower the impact of the originally expected $200 million obligation.

We expect to fund the remaining tax liability through payments over the next couple of quarters. While we evaluate capital deployment opportunities, the majority of our cash remains invested in interest-bearing accounts, generating attractive returns while maintaining ready access to capital. During the third quarter, these investments earned an average yield of approximately 3.9%, providing incremental earnings while preserving financial optionality.

In addition, our $400 million of 4.125% senior notes due in 2029 continue to provide stable, low-cost financing with no debt maturities in the near term. Turning to cash flow. Third quarter free cash flow was nearly $21 million compared with $4 million in the prior year period, aided by interest and improved quarter-over-quarter working capital. As is typical for our business, cash generation improves as the year progresses, and the fourth quarter is typically the highest cash generation period. We expect that to occur once again in 2026.

Overall, our balance sheet remains a significant source of strength, providing substantial financial flexibility as we execute our strategy, deploy capital thoughtfully and pursue opportunities to enhance long-term shareholder value.

Turning now to Slide 6 and our Packaging segment. Packaging delivered another solid quarter, driven by higher broad-based demand across our key end markets and continued execution of our cost reduction and operational excellence initiatives. Third quarter net sales increased 8.8% to $148 million, including approximately 8.2% of organic growth. As expected, growth was primarily volume-based, driven by strength across beauty and personal care, food and beverage, life sciences and industrial applications, while resin price adjustments and favorable foreign currency translation provided an additional benefit during the quarter. Operating profit increased 11.9% year-over-year to $20.4 million, reflecting higher volumes, productivity improvements and the continued execution of our cost reduction initiatives.

Operating margin expanded by 40 basis points year-over-year to 13.8%. While we did benefit from resin-based contractual price increases in the quarter, the net benefit of price/cost was more modest than anticipated as resin costs on average were higher than expected. This, coupled with a less favorable product sales mix in the third quarter, pressured margins versus our view entering the quarter. We continue to believe any impact of price/cost should generally be neutral over time as pricing mechanisms and supply chain actions help offset potential cost changes. We remain focused on partnering closely with customers and suppliers to effectively navigate the evolving environment.

Looking ahead, we remain encouraged by the underlying momentum in our Packaging segment. Our full year sales outlook of 4% to 5% sales growth includes the expected impact of the sale of our Rapak flexible bag-in-box product line, which contributed approximately $20 million of annual sales. While this divestiture lowers reported sales growth, the remainder of the packaging portfolio more than offsets the anticipated reduction in fourth quarter Rapak sales associated with the transaction. It also improves our portfolio mix given Rapak's below average margin profile.

Based on our year-to-date performance, we now expect full year operating profit margin of nearly 14%. As is typical, we expect fourth quarter sales to moderate sequentially due to normal seasonality, but both sales and operating margins are expected to improve compared to the prior year period.

We also remain focused on driving further profitability improvements through pricing discipline, operational excellence and productivity initiatives as we move into the final quarter of the year.

Turning now to Slide 7 and our Specialty Products segment. Third quarter net sales increased 2.7% year-over-year to approximately $31 million, driven by continued market share gains and solid customer demand at Norris Cylinder, partially offset by ongoing production throughput constraints. On a year-to-date basis, sales increased 9.5% to nearly $92 million.

Operating profit was $0.1 million compared to $2.4 million in the prior year period. Profitability was impacted by continuing manufacturing inefficiencies associated with the production ramp-up activities, including further machine downtime, lower labor productivity and throughput constraints, which more than offset the benefit of higher sales volumes. Results were also affected by higher steel costs due to the timing lag between raw material inflation and customer price recovery mechanisms.

We are addressing these challenges head on. First, as Tom mentioned, we have strengthened the operational leadership team at Norris Cylinder, adding significant experience and know-how on Norris' equipment. In fact, 2 key machines that experienced significant downtime in the third quarter are now operating near expected levels. We are also focused on improving production planning and scheduling, ensuring labor resources are better matched with available machine time and optimizing the sequencing of orders. So while operational challenges persisted during the quarter, we continue to view these issues as temporary and internal in nature and have solutions underway, although they are not always immediate.

Importantly, underlying demand remains healthy, supported by continuing market share gains, strong customer engagement and the value customers place on Norris Cylinder's domestic manufacturing footprint and Made in the U.S.A. designation. Looking ahead, we continue to expect Specialty Products to deliver full year sales growth of 7% to 10%. However, given the continued impact of temporary manufacturing and productivity challenges, we now expect full year operating profit margins to be in the range of 4% to 6%.

In summary, Packaging is benefiting from solid demand and ongoing operational improvement initiatives, while Specialty Products remains focused on converting strong customer demand into improved operational performance. Combined with our corporate cost reduction actions, these efforts support our objective of driving higher profitability, stronger execution and sustainable long-term growth. And with that, I'll turn the call back to Tom to discuss our outlook and priorities for the remainder of the year.

Thomas Snyder

Thanks, Paul. Turning now to our outlook on Slide 8. As we approach year-end, we have reaffirmed our adjusted earnings per share outlook of $1.60 to $1.70. This outlook reflects our performance year-to-date as well as benefits from investment income and tax-related items. As a reminder, we have not assumed any significant redeployment of the remaining aerospace divestiture proceeds during the balance of the year in our outlook. At the same time, we have modestly increased our sales outlook and now expect our Packaging and Specialty Products business to collectively deliver 4% to 6% year-over-year sales growth, reflecting the demand trends we have seen across the portfolio and including the expected impact of the Rapak divestiture.

Our margin outlook now reflects the extended throughput challenges at Norris Cylinder, and we continue to expect operating profit margin expansion of 250 basis points for the year. Our anticipated margin improvement continues to be driven primarily by the benefits of our cost reduction actions and ongoing operational improvement initiatives throughout the organization.

Looking ahead to the fourth quarter, we expect year-over-year improvement in sales, earnings and earnings per share. While the fourth quarter is typically our seasonally weakest period due to holiday schedules and lower shipment levels, we remain encouraged by the momentum across the business and the benefits of our cost reduction and operational improvement initiatives. As a result, we remain confident in our ability to deliver a year of meaningful improvement in sales, profitability and earnings while continuing to position TriMas for a future of growth.

Next, let's turn to Slide 9, which summarizes the value creation framework that has guided our actions throughout 2026. Throughout the year, we've been focused on strengthening the building blocks that we believe will drive long-term value creation at TriMas, whether through our investments in growth and innovation, our cost reduction and operational improvement initiatives, our disciplined approach to capital allocation or the continued refinement of our portfolio, each of these efforts is intended to make TriMas a stronger and more effective organization.

Importantly, many of these actions are interconnected. Stronger operational execution supports profitability, a more focused portfolio allows us to allocate resources more effectively and continued investment in innovation and customer relationships helps position us for long-term growth. While some of these initiatives are already contributing to improved results, others are still in the early stages of delivering their full potential.

Certain cost actions can be implemented and realized relatively quickly, whereas the benefits of operational excellence initiatives, organizational improvements and customer engagement efforts take -- efforts tend to build over time. We remain confident the actions we have taken throughout the year are creating a stronger foundation for future performance and positioning TriMas well for the future. As we look ahead, our priorities remain clear.

We will continue to execute our plan, invest in opportunities to support growth, maintain financial discipline and evaluate opportunities to further strengthen our portfolio and capabilities. Overall, we are pleased with the progress we have made throughout 2026. We believe TriMas is a stronger, more focused company and better positioned to capitalize on the opportunities ahead.

We are excited about the path forward, confident in our strategy and our team and remain focused on executing our priorities as we build momentum heading into 2027. Thank you. And with that, I'm going to turn it over to Sherry.

Sherry Lauderback

Thanks, Tom. At this point, we would like to open the call to questions from our analysts.

Operator

[Operator Instructions] Our first question is from Ken Newman with KeyBanc Capital Markets. This is [ Drake ] on for Ken.

分析師問答

Unknown Analyst

So I want to start off with asking about if you guys could provide any additional color on the M&A pipeline and capital allocation priorities from here. How would you characterize the pipeline today? And is life sciences still a key area of focus?

Thomas Snyder

Yes. I would say similar to what we've said in the past, we continue to be focused on those areas that hit our key strategic criteria. We are focused in areas of the life science market that we can build on in that area, also areas in the packaging business, as I've said before, that elevate our offerings and create a more premium portfolio. So we continue to be focused on that. We're very disciplined. We have an active process, but really nothing else really to add to that at this moment. Paul, do you have any further thoughts on that?

Paul Swart

No, I think activity ebbs and flows, as you can see kind of in the numbers where we disclosed what we're spending on third-party resources. So other than that, not much more specific to comment on the moment. But what we've talked about kind of in the last couple of meetings remains consistent.

Unknown Analyst

Great. And another question for me is you mentioned that the net benefit of price cost was more modest than expected in the Packaging segment. Is there a way you could help us like quantify these negative impacts that were faced this or like kind of negative impacts that were faced this quarter in terms of the Packaging segment?

Paul Swart

Yes. So if we think about what we talked about in the second quarter, we were earlier in the year, we were talking about 100 basis points of headwind that we had kind of in the first half that we expected over time to neutralize in the back half of the year, which we would have expected lots of that to come through in third quarter and then a remainder, but lesser in fourth quarter.

Less of those 100 basis points came through in third quarter. So there has been and was and still is a forecast and a projection that lots of the resins we used will come down. They did not come down as quickly as what the forecasts were that we used and gave inherent guidance on around expected more sequential improvement third quarter versus second quarter. So we do still believe that generally, we will recover them over time and especially as -- if the Middle East conflict continues to stabilize and resin prices ultimately do fall down from where they have been, given our contractual nature of our sales contracts and their adjustments, we expect that we will get that full recovery. It just didn't happen in third quarter.

Operator

Our next question is from Hamed Khorsand with BWS Financial.

Hamed Khorsand

So first off, on this sale that you announced, how much room does that create for you as far as the manufacturing is concerned? And are you looking to utilize that room in any way, if possible, for expanding into anything?

Paul Swart

So the business is primarily a couple of separate facilities. It does take up some space within one of our existing facilities that we retain. But the majority of the product line that we're selling is manufactured in specific buildings that will be going as part of the sale. So it's much more a product pruning in terms of strategically what we want to have as part of the portfolio, and that was determined to not be part of our go-forward plan, right?

Thomas Snyder

Yes. I mean the flexible business for us has never been really core. It was pretty small, not -- it's just -- we're in other end markets. And so it was something we've studied and finally executed against. And I think as we said in the prepared comments, it just helps to continue to focus us on those key markets that we feel are best for our long-term future.

Hamed Khorsand

And as you look into going Q4 and Q1, are there any changes in the seasonality concern for your packaging business?

Thomas Snyder

Well, those are Q4 and Q1 are kind of our lower quarters. Q2 and Q3 are always the strongest business times for us. A lot of building of products, relaunches, products, building inventory for seasonal sales, let's say. And so Q1 and Q4 are pretty similar. I don't see any big changes between those 2 at this point. Do you...

Paul Swart

No, I think Q4 typically is the lowest quarter historically from a revenue perspective. Certainly, this year, we have the benefit of certain actions we took earlier in the year that have the full run rate impact in Q4 that profitability is expected to be stronger than it was a year ago despite a lower comparable sales number when you adjust out for Rapak. Q1 tends to be a little bit stronger typically than Q4, but obviously, we're not providing any guidance at the moment relative to 2027.

Hamed Khorsand

And then could you just comment on free cash flow? It seems like 9 months into the year, you're still negative there and the timing, if any, if you're going to capture any of that back in Q4?

Paul Swart

Yes. So as I mentioned, free cash flow tends to move sequentially throughout the year in terms of Q4 is the low point for activity. Q1 tends to be a heavy reinvestment quarter in inventory as we prepare for selling seasons, both for Norris and packaging, which Q2 and Q3 are by far the highest sales quarters. So Q1 tends to be the inventory building period. Q2 and Q3 are still elevated inventory relative to year-end plus much higher receivables.

And then as you move into Q4, you liquidate both inventory and receivables at that point given the lower activity. So the natural ebb and flow, we think, is going to continue this year as it has in the past where Q4 should be by far the best free cash flow generation quarter of the year.

Operator

Our next question is from Ken Newman with KeyBanc Capital Markets.

Unknown Analyst

I just have a follow-up question on the Rapak divestiture, and I'm sorry if you guys have already answered it and I missed it. But is there a way to think about the impact on the packaging margin profile as we go forward and as we look into 2027?

Paul Swart

So at the moment, we're not going to disclose the specific impact relative to it, but what we did provide clarity around is that the margins of that business are below average. So it will mix us up going forward. And again, we're talking about a $20 million annual business.

Unknown Analyst

Awesome. I appreciate it. And then -- and then on Norris Cylinder, how can we -- can you discuss a little bit the expected cadence of the improvement from here? Like can we expect margins to improve sequentially into 4Q? Or is the meaningful recovery more of a 2027 event?

Paul Swart

So yes, based on our guidance, you absolutely would expect margin improvement in Q4 relative to Q3. As I mentioned, 2 of the key machines that were challenges in Q2 and certainly in Q3 currently are up and running. They both also provide some of our higher-margin products. So obviously, the key is to have sustained machine uptime in order to capitalize on all the terrific demand that, that business is experiencing. So that's why we say we think it's temporary and it's internal. It's in our control.

We need to effectively and more profitably get those orders out. And similar to what we talked about in the second quarter, we continue to throw labor and costs in order to keep the customer happy and to meet demand dates, which was a challenge with machine downtime. So given where we are today, Tom said he's encouraged, right, that we're in a much better place right now than where we were as we exited the quarter that we have much better line of sight to improvement. But yes, all of the improvement doesn't happen just in fourth quarter. We would expect that it would take a bit of time before everything is in place and gets back to kind of a sustained margin basis that we were thinking entering the year.

Unknown Analyst

Great. And then one more for me, if that's all right. I know you guys don't want to discuss 2027, so that's fine. I was just wondering if you could give any color about like what incremental margins are what we should expect as we move into 2027. But if you're not giving guidance... All right.

Thomas Snyder

All I would say is that the operational efforts that we have in place are gaining a lot of traction, as I said, we have focused plants. We're seeing really good results from the efforts in those facilities. We're going to continue to spread that model as we go into 2027 across more plants. And from a demand outlook, I mean, there's always uncertainty around that. But I think things look pretty stable from that perspective as we move into 2027. So I think that's about as much outlook as I could give you at this point.

Operator

We have reached the end of the question-and-answer session. I would like to turn the floor back over to Sherry Lauderback for closing comments.

Sherry Lauderback

Once again, thank you for joining us today and for your continued interest in TriMas. We appreciate your ongoing support, and we look forward to updating you on our progress next quarter. Thank you.

Operator

This concludes today's teleconference. You may disconnect your lines at this time. Thank you for your participation.